Janux Historical Income Statement
| JANX Stock | USD 48.82 1.49 2.96% |
Historical analysis of Janux Therapeutics income statement accounts such as Interest Expense of 4.9 M or Selling General Administrative of 13.5 M can show how well Janux Therapeutics performed in making a profits. Evaluating Janux Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Janux Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Janux Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Janux Therapeutics is a good buy for the upcoming year.
Janux |
About Janux Income Statement Analysis
Janux Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Janux Therapeutics shareholders. The income statement also shows Janux investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Janux Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Janux Therapeutics. It is also known as Janux Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Janux Therapeutics income statement and represents the costs associated with goods and services Janux Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Janux Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Janux Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.At this time, Janux Therapeutics' Net Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to rise to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 13.5 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 370K | 4.0M | 4.6M | 4.9M | Depreciation And Amortization | 113K | 841K | 2.0M | 2.1M |
Janux Therapeutics income statement Correlations
Click cells to compare fundamentals
Janux Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Janux Stock Analysis
When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.